Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Cochlear Hearing Loss

3,4-dihydroxyphenylacetic acid has been researched along with Cochlear Hearing Loss in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Han, F1
Yu, H1
Zheng, T1
Ma, X1
Zhao, X1
Li, P1
Le, L1
Su, Y1
Zheng, QY1

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Cochlear Hearing Loss

ArticleYear
Otoprotective effects of erythropoietin on Cdh23erl/erl mice.
    Neuroscience, 2013, May-01, Volume: 237

    Topics: 3,4-Dihydroxyphenylacetic Acid; Acoustic Stimulation; Analysis of Variance; Animals; Auditory Thresh

2013